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We have studied the possible involvement of nitric 
oxide (NO) in the contact hypersensitivity reaction. A 
biphasic response of ear swelling was observed at 2 h 
(early phase) and 24 h (late phase) after application of 
the antigen to picryl chloride (PCI)-sensitized CBA!] 
nllce. Intravenous injection of NO synthase inhibitor, 
NG-nitro-L-arginine methyl ester (L-NAME), at the 
tiIne of PCI challenge, inhibited in a concentration-
dependent fashion the antigen-induced contact hy-
persensitivity reaction. Low-dose (1 mg!kg) L-NAME 
inhibited the early-phase reaction but not the late-
phase reaction. High-dose (250 mg/kg) L-NAME 
inhibited both early- and late-phase reactions. 
D-NAME (enantiomer ofL-NAME) did not inhibit the 
antigen-induced ear swelling. High-dose (250 mg/kg) 
A recen t exciting find in g rega rding cellular signa lin g is that the en dothe lium-de rived relaxing facto r is ac-tually nitri c oxide (NO) . NO is syn th es izcd fi'om the amino ac id L-arginin e (Arg) by the cnzym e NO synthase (NOS) (Bredt and Sn ydcr , 1990). T he fi'ce 
radical NO .is synthcsized in mammalian sys tems suc h as iml1lunc , 
cardiovascular, and central nervous systems , w here NO acts as a 
signaling or cytotox ic molecu le. NO is gene ra ted fi'om the ox ida-
tion of the terminal g uan idin o nitrogen atolll of L-Arg b y the 
NADPH-de pende n t NOS. At least two types of NOS ha ve bee n 
identified: co nstituti ve NOS (cNOS), w hi ch is Ca2 + - depende n t, 
has been found in the e ndothe lial ce lls and in th e bra in . Indu cibl e 
NOS (iNOS), w hich is Ca2 + -ind e pend c n t, ha s becn fo und ill 
activa ted ma crophages and polymorphonuclear ce ll s. Both e nzym es 
are inhibite d ill lIillo and ill lI it m by several L-Arg analogs, inc ludin g 
NG- n itro - arginin e methyl ester (L-NAME) (Bredt and Sn yder, 
1990). 
The contact h ypersen sitivity reaction (C HR) in vo lves va ri ous 
immunocompetent cell s and m ediato rs (Gocin ski and T igelaar, 
1990). During the earl y phase fo ll owing an tigen challe n ge, ma st 
cell- d erived mediators such as histamine and se rotonin indu ce 
vasodilatio n and in crease permeability of bl ood vesse ls around th e 
site of the anti gen challe nge (Askenase ct 111 , 1983). CD4 + T cells 
are divided into two major SlIbpopulations accord ing to d iffe rences 
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L-arginine increased both early and late phase reac-
tions. D-Arginine (enantiomer of L-arginine) did not 
increase the antigen-induced ear swelling. L-NAME 
injection, however, did not suppress phenol-induced 
irritant infiamlnation. TreatInent of mice undergo-
ing PCI-induced contact hypersensitivity reaction 
with L-NAME reduced the production of interleu-
kin-2 and interferon-y by draining lymph node cells. 
Treatment with L-arginine, on the other hand, 
increased the production of interleukin-2 and inter-
feron-I'. These results suggest that NO plays a mod-
ulating role in contact hypersensitivity reaction. Key 
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552, 1996 
in lymphokin e produ c tion. Thc latc co mponent C HR T cell has 
been shown to belo ng to the Thl type, interleukin-2 (IL-2), and 
interfero n-1' (IFN-I') produ cing CD4 + subset (Che r and Mosmann, 
1987). 
l~cccntly, NO h as bee n impLicated in patho logica l conditions 
(Kolb and Ko lb-Bac hofen. 1992, Koprowski et 111.1 993), but 
parti cipatio n of NO in CHR is still obscure. In this study, we have 
in vestigated the ro lc of NO in PCI-induced CHl~ in mice. We find 
that a low dose of NOS inhibitor (1 mg/kg) reduccd the early phase 
of CHR. but not the late phasc reaction, w hil e a high dose of NOS 
inhibitor (250 mg/ kg) reduced both early- and late-phase l·eaction s. 
We have a lso in vestigated the rolc of NO in cytokine produ c tion in 
this mode L 
MATEIUALS AND METHODS 
Animals CllA /j fema le mice 6 to 8 wk old were obtaincd fr0111 C harles 
I~ver (Kanagawa , japan). The mice were rested at least 2 wk before usc. 
T hey were housed in a temperature-controlled rOOI11 and received food and 
"vater ad libitulII, Six 111icc were llsed in each cxpcril11Clltal group, alld each 
cxpcrinll!nt \vas repeated three tin1 cs. 
General Reagents 2.4 .6-Trini troch lorobenzcne (picryl chloride, PCI) 
was obta ined fr0111 Wako Pure C hemica l. Inc. (Osaka. Jap",1) . NG-Ni tro-
L-"rgininc methyl ester (L-NAM E) . its enantiomer. D-NAME, L-arginine 
(Arg) . and D-Arg were obtained fi'o m Sigma (St Louis, MO). Phenol was 
obtnined from GIBCO 8RL (Ontnrio. Canada). 
Contact Sensitization Mice were contnct sensitized by cutaneous top-
ica l appl ication of150 pJ of 5% PC I in absolute ethanol and acctone (4:1) to 
the shavcd back skin on day O. 
Measurement of Ear Swelling Responses O n day 4 the mice were 
challengcd by the topica l app lication of 1 0 p.l ofO.S'X, PC I to the left car. A 
constant area of the ea rs was l11 easured immediately before the challenge. 
and 30 min, I, 2, 3. 4. and 24 h after with a Peacock spring- loaded 
micrometer (Ozaki Co .. Tokyo, japan) . Unsensitized mice wcre also 
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Figurc 1. Two phascs ofthc CRR in CBAt} tnicc . Mice were contact 
sensiti zed by cutaneous topica l application of 150 I.d of 5'Yo PCI in absolute 
ethanol and acetone (4:1) to the shaved back skin on day O. On day 4 the 
mice were challenged by the top ical application of 1 0 fLl 0[0.8% PCI to the 
left car. Ear swelling was expressed as the difference in ear thickness before 
and after the challenge in fLm ± SO. 
challenged and used as controls for the irritant effects of 0.8% PCI. Ear 
swelling was expressed as the difference in ear thickness before and after the 
challenge in units of micrometers ± SO. Ear swelling was measured by a 
person unaware of the experi lnent's design. 
Induction of Infiatntnation by Phcnol For induction of irritant der-
matitis, 10 fLl of 20% (vol/vol) phenol in abso lute ethanol were painted on 
the ITI OUSC cat". Ear thi ckness \vas 111enslired with ~I spring-loaded miCr0l11ctcr 
at 2 and 24 h after pain ting. 
Trcatlncllt with L-NAME, D-NAME, L-Arg or D-Arg In some 
experiments, animals were injected intravenously ,with 1 mg, 50 mg or 250 
mg L-NA.ME, D-NAME. L-Arg or D-Arg per kg at the time of sensitization 
or challenge. The doses of L-NAME and L-Arg were chosen from a 
previous report (Garside er ai, 1992). Sensitization and challenge with PCI 
were performed as mentioned above. 
Gcncration and Mcasurctncnt of Cytokincs Draining lymph node 
cell s were obtained 24 h after the PCI challenge or treatment with either 
L-NAME (250 mg/ kg) or L-Arg (250 mg/kg) at the time of the challenge. 
The cell s were resuspended at 106 cell s/m l and di spensed (1 ml / well) in 
24-well plates. Cultures were stimulated with 5 fLg concanavalin A(Con A) 
per ml and supernatants obta ined at 24 h post stimulation. The levels of 
IL-2, interleukin 4 (IL-4), and IFN-y were mcasured by enzyme-linked 
immunosorbent assay kits, (Genzymc, Cambridge, MA) according to 
manufacturers' instructions. The cytokine content of each sample was read 
off from a standard curve established with the approp riate recombinant 
cytokine. 
Statistics Statistical sign ificance (p < 0.05) was ana lyzed by the Student's 
t test. H..esu lts are expressed as mean ± SO. 
RESULTS 
Changes with Time in CHR Ear swelJing was measured at 
various time intervals of30 min, 1,2,3,4,24, and 48 h after CHR 
indu ction. As shown in Fig 1, car swelling peaked at 2 and 24 h 
after CHR induction. Based on this finding, the m easure ments 
obtained at 2 and 24 h were regarded as indicators of the ea rl y and 
the late phase of CHR, respectively. 
Treatment Effects at PCI Challenge PCl-induced early phase 
ofCHR was inhibited by L-NAME (1 m g/kg, 50 mg/kg, and 250 
mg/ kg) (Fig 2). PCl-induced late phase ofCHR was inhibited only 
by high-dose L-NAME (250 m g/kg) (Fig 3). D-NAME had no 
effect on e ithe r phase (Figs 2,3). The ea rl y-phase C HR was 
in creased by L-Arg injected at doses of 50 mg/kg or 250 mg/kg, 
but no t 1 mg/kg. The late phase of C HR was increased by a hig h 
dose (250 mg/kg) but not by a lower dose ofL-Arg (Fig 3) . D-Arg 
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Figurc 2. Effcct ofL- NAME, D -NAME, L-Arg or D -Arg trcattncnt 
at thc time of PCI ehallcngc on carly phasc of CRR. Mice were 
injectcd intraveno ll sly with 1 mg. 50 mg, or 250 mg L-NAME, D-NAME, 
L-Arg or D-Arg per kg at the time of PCI challenge. *, A significant 
difference (p < 0.05) with PCI-induced C HR alonc . EI1"Or bars, mean :':: SO . 
had no effect (Figs 2,3). Ear swelling of naive (un sensitized) mice 
to 0.8% PCl at ea rl y and late phase were 11 ± 3 J.Lm and 19 ± 12 
J.Lm, respectively. 
Treatment Effects on PCI Sensitization L-NAME 
D-NAME, L-Arg, and D-Arg treatment at the t im e of PCl sen siti-
zation did not influe n ce e ither the early or late phase ofCHR (data 
not shown) . 
Cytokine Assay Lymph node cell s were prepared 2 and 24 h 
after PCl chall enge and stimulate d itl lIill'o with Con A. Cell from 
animals 24 h after PCl challenge produced significantly higher 
levels of [L-2 and [FN-y in culture compared with animals 
challenged with ethanol acetone a lone (Table I) . Injection of 
L-NAME (250 mg/kg) at the time of PCl ch allenge led to a 
significant decrease in the produc tion of these cytokines compared 
with PCl chaIJen ge without L-NAME treatment (p < 0.01 for lL-2 
and IFN-y; Table I) . Administration ofL-Arg (250 mg/kg) irr vivo 
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Figurc 3. Effcet ofL-NAME, D-NAME, L-Arg or D-Arg trcatmcnt 
at thc til11c of PCI challcngc on thc latc phasc of CRR. Mice were 
injected intravenoll sly with 1 mg, 50 mg, or 250 mg L-NAME, D-NAME, 
L-Arg or D-Arg per kg at the time of PCI challenge. *, A signi ficant 
difference (p < 0.05) with PCI-indllced CI-IR alone. Error bars, mean ± SO. 
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Table I. Effect of L-NAME or L-Arg Treatment on 
Cytokine Production by Lymph Node Cells" 
Cytokincs (pg/onl) 
Treatment IL-2 IFN-y 
Ethanol acetone 980 ± 42 60 ± 21 
PCl 19600 ± 1121 12300 ± 996 
PCI + L-NAME 14300 ± 1341/0 6800 ::': 672" 
PCl + L-Arg 24500 ± 1543' 15600 ::': 1078' 
1 tJ Lytnph node ccUs were prepared 24 h after PC l challenge ;lJtd stimulated ill I/ itro 
( with Con A (5 /-,g / m l). The leve ls of IL-2 and IFN-y (meall ± SO) measured by 
ELISA. 
& P < 0.0') compared with control. 
C p < 0.05 compared with control. 
led to a significant increase in the production of IL-2 and IFN-y by 
the lymph node cells ill "ilm compared with PCI cha llenge w ithout 
( L-Arg treatment (p < 0.05 for IL-2 and for IFN-y; Table I). IL-2 
and INF- y levels in lymph node cell cu ltures prepared 2 h afte r the 
challenge showed no significant change compared with animal s 
treated with ethanol acetone alone (data not shown) . IL-4 was not 
detectable in the supernatants of cells cultured with Con A in any 
group. 
I L-NAME Does Not Suppress Phenol-Induced Irritant In-
r 
fianllnation To examine whether L-NAME has a suppressive 
effect on nonimmunologic inflammation, we injected 250 mg/ kg 
, L-NAME or D-NAME intravenously at the time of the treatment 
with 20% phenol. Phenol induced ear swelling at 2 h after painting, 
and ear swelling decreased 24 h after phenol painting. L-NAME did 
not suppress 2-h ear swelling . T he time course of the ear swelling 
• for mice treated with L-NAME showed a pattern similar to that of 
mice treated with D-NAME, indicating no effect of L-NAME on 
phenol-induced inflammation (Table II). 
DISCUSSION 
N O is a labile humoral substance that accounts for the activity of 
endothelium-derived relaxing factor and causes vasodilation by 
relaxing vascular smooth muscle by stimu lation of soluble guany-
late cyclase (Moncada et ai, 1989). NO is rel eased from vascular 
( endot~l.eliaJ cells ill "itm in response ~o substances such as brady~­
nin, histamll1e, or 5-hydroxytryptamme (Palmer et ai, 1987). NO IS 
/ also fonned by macrophages activated by lipopolysaccharide (Lyons 
et ai, 1992) or cytokines (Kanno et ai , 1993). NO has been 
implicated in pathologic conditions such as graft-verslls-host disease 
(Garside el ai, 1992) and neurologic diseases (Koprowski el ai , 
1993). Increasing evidence suggests that NO might playa role in 
acute and chronic inflammation . Treatment with inhibitors of NOS 
reduced, whereas L-Arg enhanced, the extent of the lesions both in 
a model of acute inflammation (I alenti et ai, 1992) and in adjuvant 
arthritis in rats (McCartney el ai, 1993) . In the current study, we 
examined the participation of NO in PCI-induced CHR in mice. 
At least two different cells separately mediate the early and late 
components ofCHR that respectively are accompanied by maximal 
ear swelling at 2 and 24 h after challenge (Fig 1). T he immediate 
hypersensitivity-like early phase component of CHR is due to the 
Table II. L-NAME Does Not Suppress Phenol-Induced 
Irritant Inflammation" 
Treatment 
Phenol 
Phenol + L-NAME 
Phenol + D-NAME 
Ear Swelli ng (/-Lon) 
2 h 
192 ::': 2 1 
181 ::': 34 
187 ± 29 
24 h 
68 ± 12 
61 ::': 23 
66 ± 26 
,. Mjcc were treated with 20% phenol as described ill i\llnlcria/s {IIId J\l/cthods. Ea r 
IwelJjng (mean ± SO) wa s measured ~H 2 and 24 h after ph ell o l painting. 
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local release of vasoactive amine serotonin by mast cells (Van 
Loveren el ai, 1984). The NOS inhibitor can reduce regional and 
microvascul ar blood flow and vascular permeability (Whittle et ai, 
1989, Gardiner el ai, 1990) . The regulators of increased vascu lar 
permeabili ty and edema formation were induced by inflammatory 
events . Endogenous cNOS is involved in edema formation induced 
in the rat by substance P (Hughes el ai, 1990). cNOS generation can 
act to increase microvascular blood flow at the inflammatory site, 
leading to enhanced plasma extravasation and edema formation. 
Thus, NO appears to be generated either by the vascular endothe-
lial cells, via cNOS stimulated by some inflammatory mediators 
(histamine, 5-hydroA}'tryptaminc, bradykinin), or by the inducible 
enzym e carried to the infl ammatory site by the infiltration of 
polymorphonuclear cells or re leased by local tissues such as the 
vascular endothelium (Whittle et ai, 1989) . The findings that the 
early phase of CHR was induced by vasodilation and vasoperme-
ability to cells (Askenase ef ai, 1983) and that the low doses of NOS 
inhibitor (1 mg/kg) reduced the early phase of CHR suggest the 
possibility that this phase is mediated by vascular endothelium-
derived cNOS. 
Murine CD4 + T cells can be divided into two main subsets 
according to the cytokines they produce. Thl cells produce IL-2 
and IFN-y, which is known to induce NO production by murine 
macrophages (Stuehr and Marlettaet, 1987, Ding et ai, 1988). The 
late phase of CHR is mediated by Th1 type CD4 + T cells (Cher 
and Mosmann, 1987). In this model, lymph node cells produced 
significantly higher levels of IL-2 and IFN-y 24 h after the PCl 
challenge than animals treated with ethanol acetone alone. A high 
dose of L-NAME inhibited the late phase of CHR and decreased 
production of IL-2 and IFN-y. L-Arg increased the late phase of 
CHR and created an increase in the production ofIL-2 and IFN-y. 
The increase in 24-h ear sw elling with L-Arg was significant, but 
only approximately 33%. These changes are statistically significant 
but do not indicate that NO has a major role in the pathogenesis of 
the classic 24-h allergic contact hypersensitivity ear-swelling re-
sponse. It is more likely that the partial deficiency in tile 24-h 
response reflects inh.ibition of necessary early events. A low dose of 
NOS inhibitor did not inhibit the late-phase response, indicating 
the possibility that a low dose of L-NAME d id not reduce iNOS 
formation. Intravenous injection ofL-NAME and L-Arg at tlle time 
of the PCI challenge modulated the CHR but had no effect when 
injected at the time of PCI sensitization. This evidence indicates 
that NO may playa role in the efferent phase ofCHR but not in the 
afferent phase . T he lack of a suppressive effect by L-NAME on 
phenol-indu ced inflammation suggests that NO is not required for 
the induction of irritant dermatitis. 
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